Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2000
10/11/2000EP1041995A1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
10/11/2000EP1041994A1 Use of parasitic biological agents for prevention and control of autoimmune diseases
10/11/2000EP1041991A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/11/2000EP1041990A1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
10/11/2000EP1041989A1 Novel cycloalkenyl substituted compounds
10/11/2000EP1041987A1 Opioid agonist/antagonist combinations
10/11/2000EP1041986A1 Pharmaceutically active compound and methods of use
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000EP1041977A1 USE OF PPAR-$g(g) ACTIVATORS IN DERMATOLOGY
10/11/2000EP1041969A2 Novel pharmaceutical compositions of uridine triphosphate
10/11/2000EP1041966A2 Pharmaceutical compositions
10/11/2000EP1041956A1 Mixture for the oxidation tinting of keratin fibres containing a laccase and tinting method using said mixture
10/11/2000EP1041880A1 A delivery of arginine to cause beneficial effects
10/11/2000EP0778768A4 Formulations and methods for providing prolonged local anesthesia
10/11/2000EP0650485B1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
10/11/2000CN1269832A Kay-novel immune system protein
10/11/2000CN1269804A CTL epitopes from EBV
10/11/2000CN1269792A Novel carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin-receptor atagonists
10/11/2000CN1269785A Aromatic C16-C20 substituted tetrahydro prostaglandius useful as EP agonists
10/11/2000CN1269784A Aromatic C16-C20 substituted tetrahydro prostagladins useful as FP agonists
10/11/2000CN1269729A Composition for releiving inflamation and product thereof
10/11/2000CN1269726A Fracture healing using PTHrp analogs
10/11/2000CN1269725A Product comprising at least double stranded RNA combined with at least an antiviral agent
10/11/2000CN1269724A Absorption of minerals by intestinal cells
10/11/2000CN1269722A Method and composition for modulating responsiveness to corticosteroids
10/11/2000CN1269721A Method for increasing bone volumn using non-naturally-occuring EP selective agonists
10/11/2000CN1269718A Methods and compositions for reducing the incidence of necrotizing enterocolitis
10/11/2000CN1269715A Method and composition for treating late allergic reactions and inflammation diseases
10/11/2000CN1269218A Medicated health tea
10/11/2000CN1057295C Sulfonamide endothelin antagonists and use thereof
10/11/2000CN1057226C Oral liquor for giving-up drug-taking and preparation method
10/11/2000CN1057209C Pill for blacking hair and strenthening body
10/11/2000CN1057207C Composition for treating osteoporosis
10/10/2000US6130325 Human P24 vesicle proteins
10/10/2000US6130254 Methods for inhibiting photoaging of skin
10/10/2000US6130239 Inhibit cyclin-dependent kinases
10/10/2000US6130234 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
10/10/2000US6130233 Methods and compositions for treating allergic disorders and other disorders using metabolic derivatives of astemizole
10/10/2000US6130231 Integrin receptor antagonists
10/10/2000US6130230 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
10/10/2000US6130227 7-Substituted camptothecin derivatives and methods for inhibiting the growth of tumor cells therewith
10/10/2000US6130223 Thienopyrimidine with phosphodiesterase V inhibiting effect
10/10/2000US6130216 Use of thiazolidinedione derivatives in the treatment of insulin resistance
10/10/2000US6130088 Antisense modulation of telomeric repeat binding factor 1 expression
10/10/2000US6130071 Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof
10/10/2000US6130064 Amino acid sequence encoded by polynucleotide from survival motor neuron gene; diagnosis, treatment, and prevention of nervous system, reproductive, and cell proliferative disorders; antiproliferative/anticarcinogenic agents
10/10/2000US6130062 Production of proteins in host cells
10/10/2000US6130060 Gene encoding for adseverin
10/10/2000US6129911 Liver stem cell
10/10/2000CA2067475C Carbostyril derivatives and their use
10/08/2000CA2303765A1 Cml therapy
10/05/2000WO2000058512A1 Antisense modulation of interleukin-5 signal transduction
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058472A2 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same
10/05/2000WO2000058467A1 50 human secreted proteins
10/05/2000WO2000058466A2 Protease resistant flint analogs
10/05/2000WO2000058465A2 Flint polypeptide analogs
10/05/2000WO2000058361A1 Melanocortin receptor ligands
10/05/2000WO2000058359A1 Retro-inverso prosaposin-derived peptides and use thereof
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058341A1 Hookworm platelet inhibitor
10/05/2000WO2000058340A2 50 human secreted proteins
10/05/2000WO2000058337A1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
10/05/2000WO2000058336A1 50 human secreted proteins
10/05/2000WO2000058313A1 4-substituted quinoline derivatives as gaba receptor ligands
10/05/2000WO2000058312A1 Compounds capable of cleaving double-stranded dna and method of utilization of the same
10/05/2000WO2000058309A1 Derivatives of pyrimido[6,1-a]isoquinolin-4-one
10/05/2000WO2000058308A1 DERIVATIVES OF PYRIMIDO[6,1-a]ISOQUINOLIN-4-ONE
10/05/2000WO2000058307A2 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058304A1 Heterocyclic sulfonamide derivatives
10/05/2000WO2000058303A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
10/05/2000WO2000058296A1 Protease inhibitors
10/05/2000WO2000058295A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000WO2000058294A1 Antibacterial agents
10/05/2000WO2000058293A2 Glucokinase activators
10/05/2000WO2000058271A1 Nitrogen mustard compounds and prodrugs therefor
10/05/2000WO2000057922A1 Intramyocardial injection of autologous bone marrow
10/05/2000WO2000057920A2 Method for expressing proteins
10/05/2000WO2000057899A1 Thrombospondin-2 and uses thereof
10/05/2000WO2000057897A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000WO2000057896A1 Modulators of polysaccharides and uses thereof
10/05/2000WO2000057889A1 Skin preparations for external use
10/05/2000WO2000057883A1 Use of vasopeptidase inhibitors to treat angina pectoris
10/05/2000WO2000057877A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/05/2000WO2000057870A2 Viral treatment
10/05/2000WO2000057868A2 Use of carbamamic acid derivatives for the treatment of viral infections
10/05/2000WO2000057865A2 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
10/05/2000WO2000057864A2 Cyclic glycerophosphates and analogs thereof
10/05/2000WO2000057863A2 Use of pyridoxine compounds for treatment of cardiovascular and related pathologies
10/05/2000WO2000057854A2 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances
10/05/2000WO2000057837A2 Compositions and methods for effecting the levels of cholesterol
10/05/2000WO2000042026B1 Non-peptide glp-1 agonists
10/05/2000WO2000040217B1 Topical composition comprising n-acetylaldosamines or n-acetylamino acids
10/05/2000WO2000031133A3 Potassium channel interactors and uses therefor
10/05/2000WO2000030588A3 Treatment of hypertension
10/05/2000WO2000026246A3 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
10/05/2000WO2000023088A3 Methods of administering adenoviral vectors
1 ... 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 ... 1564